99 related articles for article (PubMed ID: 9264354)
1. Prognostic factors in idiopathic (primary) osteomyelofibrosis.
Kvasnicka HM; Thiele J; Werden C; Zankovich R; Diehl V; Fischer R
Cancer; 1997 Aug; 80(4):708-19. PubMed ID: 9264354
[TBL] [Abstract][Full Text] [Related]
2. Idiopathic primary osteo-myelofibrosis: a clinico-pathological study on 208 patients with special emphasis on evolution of disease features, differentiation from essential thrombocythemia and variables of prognostic impact.
Thiele J; Kvasnicka HM; Werden C; Zankovich R; Diehl V; Fischer R
Leuk Lymphoma; 1996 Jul; 22(3-4):303-17. PubMed ID: 8819080
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of apoptosis and proliferation in idiopathic (primary) myelofibrosis.
Kvasnicka HM; Thiele J; Regn C; Zankovich R; Diehl V; Fischer R
Ann Hematol; 1999 Feb; 78(2):65-72. PubMed ID: 10089020
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic factors and survival in chronic myeloproliferative disorders].
Kvasnicka HM; Thiele J; Schmitt-Graeff A; Schaefer HE
Pathologe; 2000 Jan; 21(1):63-72. PubMed ID: 10663670
[TBL] [Abstract][Full Text] [Related]
5. Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis.
Thiele J; Kvasnicka HM; Zankovich R; Diehl V
Haematologica; 2000 Nov; 85(11):1126-34. PubMed ID: 11064463
[TBL] [Abstract][Full Text] [Related]
6. Primary myelofibrosis-osteomyelosclerosis (agnogenic myeloid metaplasia): correlation of clinical findings with bone marrow histopathology and prognosis.
Thiele J; Steinberg T; Zankovich R; Fischer R
Anticancer Res; 1989; 9(2):429-35. PubMed ID: 2751268
[TBL] [Abstract][Full Text] [Related]
7. The impact of clinicopathological studies on staging and survival in essential thrombocythemia, chronic idiopathic myelofibrosis, and polycythemia rubra vera.
Kvasnicka HM; Thiele J
Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):362-71. PubMed ID: 16810612
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of bone marrow reticulin fibres in idiopathic myelofibrosis: evaluation of clinicopathological parameters in a scoring system.
Iványi JL; Mahunka M; Papp A; Kiss A; Telek B
Haematologia (Budap); 1994; 26(2):75-86. PubMed ID: 7890265
[TBL] [Abstract][Full Text] [Related]
9. Chronic idiopathic myelofibrosis: prognostic impact of myelofibrosis and clinical parameters on event-free survival in 122 patients who presented in prefibrotic and fibrotic stages. A retrospective study identifying subgroups of different prognoses by using the RECPAM method.
Kreft A; Weiss M; Wiese B; Choritz H; Buhr T; Büsche G; Georgii A
Ann Hematol; 2003 Oct; 82(10):605-11. PubMed ID: 14564478
[TBL] [Abstract][Full Text] [Related]
10. Age and hemoglobin level emerge as most important clinical prognostic parameters in patients with osteomyelofibrosis: introduction of a simplified prognostic score.
Strasser-Weippl K; Steurer M; Kees M; Augustin F; Tzankov A; Dirnhofer S; Fiegl M; Simonitsch-Klupp I; Zojer N; Gisslinger H; Ludwig H
Leuk Lymphoma; 2006 Mar; 47(3):441-50. PubMed ID: 16396767
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow features improve prognostic efficiency in multivariate risk classification of chronic-phase Ph(1+) chronic myelogenous leukemia: a multicenter trial.
Kvasnicka HM; Thiele J; Schmitt-Graeff A; Diehl V; Zankovich R; Niederle N; Leder LD; Schaefer HE
J Clin Oncol; 2001 Jun; 19(12):2994-3009. PubMed ID: 11408494
[TBL] [Abstract][Full Text] [Related]
12. Grade of bone marrow fibrosis is associated with relevant hematological findings-a clinicopathological study on 865 patients with chronic idiopathic myelofibrosis.
Thiele J; Kvasnicka HM
Ann Hematol; 2006 Apr; 85(4):226-32. PubMed ID: 16421727
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological diagnosis and differential criteria of thrombocythemias in various myeloproliferative disorders by histopathology, histochemistry and immunostaining from bone marrow biopsies.
Thiele J; Kvasnicka HM; Diehl V; Fischer R; Michiels J
Leuk Lymphoma; 1999 Apr; 33(3-4):207-18. PubMed ID: 10221501
[TBL] [Abstract][Full Text] [Related]
14. The syndrome of idiopathic myelofibrosis. A clinicopathologic review with emphasis on the prognostic variables predicting survival.
Varki A; Lottenberg R; Griffith R; Reinhard E
Medicine (Baltimore); 1983 Nov; 62(6):353-71. PubMed ID: 6633248
[TBL] [Abstract][Full Text] [Related]
15. Idiopathic myelofibrosis: a retrospective study of 103 patients.
Anger B; Seidler R; Haug U; Popp C; Heimpel H
Haematologica; 1990; 75(3):228-34. PubMed ID: 2227619
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic myelofibrosis (agnogenic myeloid metaplasia): clinicopathological analysis of 32 patients.
Ozen S; Ferhanoğlu B; Senocak M; Tüzüner N
Leuk Res; 1997 Feb; 21(2):125-31. PubMed ID: 9112429
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic myelofibrosis.
Barosi G; Hoffman R
Semin Hematol; 2005 Oct; 42(4):248-58. PubMed ID: 16210038
[TBL] [Abstract][Full Text] [Related]
18. Myelofibrosis with myeloid metaplasia: diagnosis, prognostic factors, and staging.
Cervantes F; Barosi G
Semin Oncol; 2005 Aug; 32(4):395-402. PubMed ID: 16202685
[TBL] [Abstract][Full Text] [Related]
19. CD34+ stem cells in chronic myeloproliferative disorders.
Thiele J; Kvasnicka HM
Histol Histopathol; 2002 Apr; 17(2):507-21. PubMed ID: 11962756
[TBL] [Abstract][Full Text] [Related]
20. 'Classic' and 'acute' myelofibrosis. A retrospective study.
Rojer RA; Mulder NH; Nieweg HO
Acta Haematol; 1978; 60(2):108-16. PubMed ID: 98950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]